CHOSA — Chosa Oncology AB Balance Sheet
0.000.00%
Last trade - 00:00- SEK67.14m
- SEK59.40m
- SEK0.07m
Annual balance sheet for Chosa Oncology AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | Interim Report | ARS |
| Standards: | SAS | SAS | SAS | — | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 130 | 77.5 | 29.6 | 15.1 | 8.77 |
| Net Total Receivables | 5.99 | 9.8 | 10.3 | 10.5 | 0.753 |
| Prepaid Expenses | |||||
| Total Current Assets | 150 | 102 | 55.8 | 30.1 | 9.53 |
| Net Intangible Assets | |||||
| Total Assets | 150 | 102 | 55.8 | 30.1 | 19.4 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 12.6 | 7.15 | 14.1 | 20.7 | 2.02 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 12.6 | 7.15 | 14.1 | 20.7 | 2.02 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 137 | 94.8 | 41.7 | 9.39 | 17.4 |
| Total Liabilities & Shareholders' Equity | 150 | 102 | 55.8 | 30.1 | 19.4 |
| Total Common Shares Outstanding |